Our preliminary results show strong expression of GPBAR1 protein in LNCaP, PC-3 and DU-145 cells and we are currently investigating the role of this receptor in triggering various cell death or survival pathways in these prostate cancer cells. Here, GPBAR1 is linked to prostate carcinoma.